In-Depth Market Research Report 2021 on Global Polyoxin Market with Industry Growth Analysis, Competitor Analysis, Product & Applications Analysis, Regional Trends and Forecast by 2026.

The Global Polyoxin Market report offers actionable data through the SWOT analysis, Porters Five Analysis, Competitors Analysis, Products and Sales Analysis. It also includes the major market situations across the globe such as the product profit, price, production, capacity, demand, supply, as well as market growth structure. The report on the Global Polyoxin Market has been prepared after conducting a comprehensive research through a systematized methodology. This report will help you to make your business decisions in upcoming years as report data is forecasted precisely to 2026 by applying all the matrices.

The report covers market shares, CAGR, sales, gross margin, value, volume, and other important market statistics and figures that give an exact picture of the growth of the global Polyoxin market.

Get The Sample Report PDF with Detail TOC & List of Figures@https://www.apexmarketsresearch.com/report/global-polyoxin-market-by-product-type-wettable-powder-905970/?utm_source=Tanuj&utm_medium=Tanuj#sample

The report also provides detail study on the trending innovations, business models, growth factors and every information about the big companies that will be present in the future market insights. Every market consists of set of manufacturers, vendors and consumers that gives a definition to the market, its each and every move, achievements. All these important subjects are covered in this report.

The report covers following Top Companies Data:

Jiangsu Fengyuan Bioengineering Co., Ltd., Beijing Green Agrosino Co., Ltd., Kaken Pharmaceutical Co., Ltd., Nufarm Limited, Arysta LifeScience, Certis, OHP Inc., Cleary Chemical Corp., Hanzhou Dayangchem Co. Ltd., Shanxi Lvhai Agrochemicals

The Polyoxin Market report has been segregated based on distinct categories, such as product type, application, end user, and region. Each and every segment is evaluated on the basis of CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is estimated to generate opportunities in the global Polyoxin market in the forthcoming years. This segmental analysis will surely turn out to be a useful tool for the readers, stakeholders, and market participants to get a complete picture of the global Polyoxin market and its potential to grow in the years to come.

Market Segmentation by Product Types:

Wettable Powder (WP)Dustable Powder (DP)Emulsifiable Concentrate (EC)

Market Segmentation by Applications:

GrainFruitsVegetablesOthers

This research report is segmented into several key regions, with the market production, consumption, revenue and market share.

North America (U.S., Canada, Mexico) Europe (Germany, U.K., France, Italy, Russia, Spain, and Rest of Europe) Asia Pacific (China, Japan, India, Russia, and Rest of Asia Pacific) Latin America (Cuba, Brazil, Argentina, and Rest of Latin America) Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)

FAQS in the report:What are the growth opportunities of the Polyoxin market?Which application/end-user category or Product Type may seek incremental growth prospects?What is the market concentration? Is it fragmented or highly concentrated?Which regional market will dominate in coming years?Which region may tap highest market share in coming era?What are the key challenges that the global Polyoxin market may face in future?Which are the leading players in the global Polyoxin market?What trends, challenges and barriers will impact the development and sizing of Global Polyoxin market?Which are the growth strategies considered by the players to sustain hold in the global Polyoxin market?What will be the post COVID-19 market scenario?What growth momentum or acceleration market carries during the forecast period?

For More Queries and Customization in The Report@https://www.apexmarketsresearch.com/report/global-polyoxin-market-by-product-type-wettable-powder-905970/?utm_source=Tanuj&utm_medium=Tanuj#inquiry

TOC for the Global Polyoxin Market:

Chapter 1 Industry Overview

1.1 Polyoxin Market Overview1.1.1 Polyoxin Product Scope1.1.2 Market Status and Outlook1.2 Global Polyoxin Market Size and Analysis by Regions (2014-2019)1.2.1 North America Polyoxin Market Status and Outlook1.2.2 EU Polyoxin Market Status and Outlook1.2.3 Japan Polyoxin Market Status and Outlook1.2.4 China Polyoxin Market Status and Outlook1.2.5 India Polyoxin Market Status and Outlook1.2.6 Southeast Asia Polyoxin Market Status and Outlook1.3 Global Polyoxin Market Segment by Types (2014-2026)1.3.1 Global Polyoxin Revenue and Growth Rate Comparison by Types (2014-2026)1.3.2 Global Polyoxin Revenue Market Share by Types in 20181.3.3 Type11.3.4 Type21.3.5 OtherOthers1.4 Polyoxin Market by End Users/Application1.4.1 Global Polyoxin Revenue (USD Mn) Comparison by Applications (2014-2026)1.4.2 Application 11.4.3 Application 2

Chapter 2 Global Polyoxin Competition Analysis by Players

2.1 Global Polyoxin Market Size (Million USD) by Players (2014-2019)2.2 Competitive Status and Trend2.2.1 Market Concentration Rate2.2.2 Product/Service Differences2.2.3 New Entrants2.2.4 The Technology Trends in Future

Chapter 3 Company (Top Players) Profiles and Key Data

3.1 Company 13.1.1 Company Profile3.1.2 Main Business/Business Overview3.1.3 Products, Services and Solutions3.1.4 Company 1, Polyoxin Revenue (Million USD) (2014-2019)3.1.5 Recent Developments3.2 Company 23.2.1 Company Profile3.2.2 Main Business/Business Overview3.2.3 Products, Services and Solutions3.2.4 Company 2, Polyoxin Revenue (Million USD) (2014-2019)3.2.5 Recent Developments3.3 Company 33.3.1 Company Profile3.3.2 Main Business/Business Overview3.3.3 Products, Services and Solutions3.3.4 Company 3, Polyoxin Revenue (Million USD) (2014-2019)3.3.5 Recent DevelopmentsAnd more

Chapter 4 Global Polyoxin Market Size Type (2014-2019)

4.1 Global Polyoxin Market Size by Type (2014-2019)

Chapter 5 Global Polyoxin Market Size Application (2014-2019)

5.1 Global Polyoxin Market Size by Application (2014-2019)5.2 Potential Application of Polyoxin in Future5.3 Top Consumer / End Users of Polyoxin

Chapter 6 North America Polyoxin Development Status and Outlook

6.1 North America Polyoxin Market Size (2014-2019)6.2 North America Polyoxin Market Size by Application (2014-2019)

Chapter 7 EU Polyoxin Development Status and Outlook

7.1 EU Polyoxin Market Size (2014-2019)7.2 EU Polyoxin Market Size by Application (2014-2019)

Chapter 8 Japan Polyoxin Development Status and Outlook

8.1 Japan Polyoxin Market Size (2014-2019)8.2 Japan Polyoxin Market Size by Application (2014-2019)

Chapter 9 China Polyoxin Development Status and Outlook

9.1 China Polyoxin Market Size and Forecast (2014-2019)9.2 China Polyoxin Market Size by Application (2014-2019)

Chapter 10 India Polyoxin Development Status and Outlook

10.1 India Polyoxin Market Size and Forecast (2014-2019)10.2 India Polyoxin Market Size by Application (2014-2019)

Chapter 11 Southeast Asia Polyoxin Development Status and Outlook

11.1 Southeast Asia Polyoxin Market Size and Forecast (2014-2019)11.2 Southeast Asia Polyoxin Market Size by Application (2014-2019)

Chapter 12 Market Forecast by Regions and Application (2019-2026)

12.1 Global Polyoxin Market Size (Million USD) by Regions (2019-2026)12.1. North America Polyoxin Revenue and Growth Rate (2019-2026)12.1.2 EU Polyoxin Revenue and Growth Rate (2019-2026)12.1.3 China Polyoxin Revenue and Growth Rate (2019-2026)12.1.4 Japan Polyoxin Revenue and Growth Rate (2019-2026)12.1.5 Southeast Asia Polyoxin Revenue and Growth Rate (2019-2026)12.1.6 India Polyoxin Revenue and Growth Rate (2019-2026)12.2 Global Polyoxin Market Size by Application (2019-2026)

Chapter 13 Polyoxin Market Dynamics

13.1 Polyoxin Market Opportunities13.2 Polyoxin Challenge and Risk13.2.1 Competition from Opponents13.2.2 Downside Risks of Economy13.3 Polyoxin Market Constraints and Threat13.3.1 Threat from Substitute13.3.2 Government Policy13.3.3 Technology Risks13.4 Polyoxin Market Driving Force13.4.1 Growing Demand from Emerging Markets13.4.2 Potential Application

Chapter 14 Market Effect Factors Analysis

14.1 Technology Progress/Risk14.1.1 Substitutes14.1.2 Technology Progress in Related Industry14.2 Consumer Needs Trend/Customer Preference14.3 External Environmental Change14.3.1 Economic Fluctuations14.3.2 Other Risk Factors

Chapter 15 Research Finding /Conclusion

Chapter 16 Methodology and Data Source

16.1 Methodology/Research Approach16.1.1 Research Programs/Design16.1.2 Market Size Estimation16.1.3 Market Breakdown and Data Triangulation16.2 Data Source16.2.1 Secondary Sources16.2.2 Primary Sources16.3 Disclaimer16.4 Author List

About Us:We at Apex Market Research aim to be global leaders in qualitative and predictive analysis as we put ourselves in the front seat for identifying worldwide industrial trends and opportunities and mapping them out for you on a silver platter. We specialize in identifying the calibers of the markets robust activities and constantly pushing out the areas which allow our clientele base in making the most innovative, optimized, integrated and strategic business decisions in order to put them ahead of their competition by leaps and bounds. Our researchers achieve this mammoth of a task by conducting sound research through many data points scattered through carefully placed equatorial regions.

Contact Us:Apex Market Research1st Floor, Harikrishna Building,Samarth Nagar, New Sanghvi,Pune- 411027 Indiatel: +91-8149441100 (GMT Office Hours)tel: +17738002974sales@apexmarketsresearch.com

Follow this link:
Polyoxin Market In Depth Research with Global Industry Analysis, Size, Trends and Forecast by 2026 | Jiangsu Fengyuan Bioengineering Co., Ltd.,...

This past week, the Harvard community witnessed the rightful cancelation of Kevin K. Kit Parkers course, Engineering Sciences 298R: Data Fusion in Complex Systems: A Case Study. The course planned to have undergraduates examine the efficacy of policing criminal activity in Springfield, Mass. using a policing tactic modeled after how troops in America's wars in Iraq and Afghanistan conducted counterinsurgency.

Examining Springfields Counter Criminal Continuum Policing program C3 for short has become something of a pet project for Parker, a bioengineering professor. A personal connection helps explain why.

Parker and Matthew M. Cutone, the state trooper that trademarked C3, connected over the idea of bringing wartime tactics home in 2011 while in the same National Guard training unit. The army buddies, as Parker puts it, have had a working relationship for over a decade, which has included collaborating on a Harvard course in 2012.

During this 2012 class the canceled courses predecessor undergraduates developed intelligence collection software that Springfield cops used to create a database of suspected gang members to target based on information including an individuals tattoos. Cutone, the cop who invented the C3 strategy, gave undergraduates a tour of Springfield as a part of the course to determine if, after their intervention, any of the symptoms of that failed community had been alleviated, according to the 60 Minutes interview on the project Parker used to promote this years failed iteration of the course.

To be clear, thinking critically about police tactics is not inherently wrong. Responsibly studying difficult and controversial topics matters, perhaps more so for their difficulty. However, Parkers approach and personal ties to C3s creator deeply alarm us.

Parkers course was never chiefly about data; rather, it seems clear that ES 298R was meant to serve as a laboratory, as he puts it, for justifying the use of military tactics in Springfield, Mass.

Parker has indicated support for C3: Cutone, its creator, says Parker's eyes lit up upon hearing the idea. In a 2013 interview, Parker described insurgents in Afghanistan and gangs in the inner city as operating off the same business model, and expressed confidence that military counterinsurgency belongs in U.S. policing. On the subject, Parker, a veteran, said I do want to win one war in my life. I didn't fight in Iraq, I fought in Afghanistan. I want to win one counterinsurgency. To do so, the bioengineering professor has made the majority-minority neighborhood of Springfield his battleground and enlisted Harvard undergraduates as foot soldiers.

Cutone, Parkers decade-old friend and collaborator, appears to profit off of C3 policing. In addition to creating the tactic, Cutone runs a consulting company that exports it, lending weight to the question of whether Parker has improper financial connections to C3, which Parker denies, raised in the petition that led to ES 298Rs cancelation. Publicity-driven incentives could have also led the bioengineering professor to revisit his interest in policing. The last time Parker taught his C3 policing course (which, again, allowed untrained undergraduates to direct police operations), a flurry of press followed: a 60 Minutes interview, a profile in Nature, and a New York Times piece, all of which he used to promote this years botched iteration of the course.

Yet our issues with the course go well beyond the instructors background and potential conflicts of interest. ES 298R was also a course about policing that declined to wrestle with the inherent racial dynamics of its field of study; a course that, though predicated on studying the institution that helped unleash months-long protests over the deadly mistreatment of minorities, took the time to make clear that racial disparities were not the focus of its work.

One cannot sideline ethics for the sake of teaching a data-driven course, nor, by the use of buzzwords like data-driven alone, banish the racial biases that permeate debates about policing and infect police data. Parkers own attempt to teach ES 298R with an emphasis on criminal gangs and gang activity without proper acknowledgement of the racial character and history of such terms (what makes one group a gang and another a right-wing militia?) is a brutal display of ignorance. Objective analysis that ignores historical and social backdrop is hardly objective.

You cannot have a class on policing without conversation on race especially not one based in a majority-minority city like Springfield, where only 29 percent of residents self-identify as white. We know that the American police system is racist. Its practices disproportionately target Black, Latinx, and indigenous communities in the United States; tactics like stop-and-frisk have even codified this terrorizing. Sidelining these disparities in a class centered on police tactics is to teach a tone deaf and painfully inaccurate view of American policing. To examine C3s effect on quality of life, as ES 298Rs course description proposes, while carpeting over equity is absurd. Under Parkers framework, we doubt the crucial fact that, in 2020, the Justice Department found Springfield police engaged in an unconstitutional pattern of excessive force would even factor into quality-of-life considerations.

That Parkers course, a seeming ploy to use students to prop up literally militaristic policing, was ever offered is a nightmare. Harvard must urgently commit to ensuring that such glaringly immoral and ill-conceived coursework is never offered again. Courses that task students with coding away deep societal issues obviously and especially warrant scrutiny.

This staff editorial solely represents the majority view of The Crimson Editorial Board. It is the product of discussions at regular Editorial Board meetings. In order to ensure the impartiality of our journalism, Crimson editors who choose to opine and vote at these meetings are not involved in the reporting of articles on similar topics.

Have a suggestion, question, or concern for The Crimson Editorial Board? Click here.

Continued here:
The Harvard Class Where Undergrads Play Police | Opinion - Harvard Crimson

LOS ANGELES, United States: QY Research has recently published a research report titled, Global Agricultural Animal Vaccine Sales Market Report 2020. This report has been prepared by experienced and knowledgeable market analysts and researchers. It is a phenomenal compilation of important studies that explore the competitive landscape, segmentation, geographical expansion, and revenue, production, and consumption growth of the global Agricultural Animal Vaccine market. Players can use the accurate market facts and figures and statistical studies provided in the report to understand the current and future growth of the global Agricultural Animal Vaccine market.

The report includes CAGR, market shares, sales, gross margin, value, volume, and other vital market figures that give an exact picture of the growth of the global Agricultural Animal Vaccine market.

Competitive Landscape

Competitor analysis is one of the best sections of the report that compares the progress of leading players based on crucial parameters, including market share, new developments, global reach, local competition, price, and production. From the nature of competition to future changes in the vendor landscape, the report provides in-depth analysis of the competition in the global Agricultural Animal Vaccine market.

Key questions answered in the report:

TOC

1 Agricultural Animal Vaccine Market Overview1.1 Agricultural Animal Vaccine Product Scope1.2 Agricultural Animal Vaccine Segment by Type1.2.1 Global Agricultural Animal Vaccine Sales by Type (2020-2026)1.2.2 Live Attenuated Vaccines1.2.3 Inactivated Vaccines1.2.4 Others1.3 Agricultural Animal Vaccine Segment by Application1.3.1 Global Agricultural Animal Vaccine Sales Comparison by Application (2020-2026)1.3.2 Cow1.3.3 Sheep1.3.4 Swine1.3.5 Chicken1.3.6 Others1.4 Agricultural Animal Vaccine Market Estimates and Forecasts (2015-2026)1.4.1 Global Agricultural Animal Vaccine Sales Growth Rate (2015-2026)1.4.2 Global Agricultural Animal Vaccine Revenue and Growth Rate (2015-2026)1.4.3 Global Agricultural Animal Vaccine Price Trends (2015-2026) 2 Agricultural Animal Vaccine Estimate and Forecast by Region2.1 Global Agricultural Animal Vaccine Market Size by Region: 2015 VS 2020 VS 20262.2 Global Agricultural Animal Vaccine Retrospective Market Scenario by Region (2015-2020)2.2.1 Global Agricultural Animal Vaccine Sales Market Share by Region (2015-2020)2.2.2 Global Agricultural Animal Vaccine Revenue Market Share by Region (2015-2020)2.3 Global Agricultural Animal Vaccine Market Estimates and Forecasts by Region (2021-2026)2.3.1 Global Agricultural Animal Vaccine Sales Estimates and Forecasts by Region (2021-2026)2.3.2 Global Agricultural Animal Vaccine Revenue Forecast by Region (2021-2026)2.4 Geographic Market Analysis: Market Facts & Figures2.4.1 United States Agricultural Animal Vaccine Estimates and Projections (2015-2026)2.4.2 Europe Agricultural Animal Vaccine Estimates and Projections (2015-2026)2.4.3 China Agricultural Animal Vaccine Estimates and Projections (2015-2026)2.4.4 Japan Agricultural Animal Vaccine Estimates and Projections (2015-2026)2.4.5 Southeast Asia Agricultural Animal Vaccine Estimates and Projections (2015-2026)2.4.6 India Agricultural Animal Vaccine Estimates and Projections (2015-2026) 3 Global Agricultural Animal Vaccine Competition Landscape by Players3.1 Global Top Agricultural Animal Vaccine Players by Sales (2015-2020)3.2 Global Top Agricultural Animal Vaccine Players by Revenue (2015-2020)3.3 Global Agricultural Animal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Agricultural Animal Vaccine as of 2019)3.4 Global Agricultural Animal Vaccine Average Price by Company (2015-2020)3.5 Manufacturers Agricultural Animal Vaccine Manufacturing Sites, Area Served, Product Type3.6 Manufacturers Mergers & Acquisitions, Expansion Plans3.7 Primary Interviews with Key Agricultural Animal Vaccine Players (Opinion Leaders) 4 Global Agricultural Animal Vaccine Market Size by Type4.1 Global Agricultural Animal Vaccine Historic Market Review by Type (2015-2020)4.1.1 Global Agricultural Animal Vaccine Sales Market Share by Type (2015-2020)4.1.2 Global Agricultural Animal Vaccine Revenue Market Share by Type (2015-2020)4.1.3 Global Agricultural Animal Vaccine Price by Type (2015-2020)4.2 Global Agricultural Animal Vaccine Market Estimates and Forecasts by Type (2021-2026)4.2.1 Global Agricultural Animal Vaccine Sales Forecast by Type (2021-2026)4.2.2 Global Agricultural Animal Vaccine Revenue Forecast by Type (2021-2026)4.2.3 Global Agricultural Animal Vaccine Price Forecast by Type (2021-2026) 5 Global Agricultural Animal Vaccine Market Size by Application5.1 Global Agricultural Animal Vaccine Historic Market Review by Application (2015-2020)5.1.1 Global Agricultural Animal Vaccine Sales Market Share by Application (2015-2020)5.1.2 Global Agricultural Animal Vaccine Revenue Market Share by Application (2015-2020)5.1.3 Global Agricultural Animal Vaccine Price by Application (2015-2020)5.2 Global Agricultural Animal Vaccine Market Estimates and Forecasts by Application (2021-2026)5.2.1 Global Agricultural Animal Vaccine Sales Forecast by Application (2021-2026)5.2.2 Global Agricultural Animal Vaccine Revenue Forecast by Application (2021-2026)5.2.3 Global Agricultural Animal Vaccine Price Forecast by Application (2021-2026) 6 United States Agricultural Animal Vaccine Market Facts & Figures6.1 United States Agricultural Animal Vaccine Sales Market Share by Company (2015-2020)6.2 United States Agricultural Animal Vaccine Sales Market Share by Type (2015-2020)6.3 United States Agricultural Animal Vaccine Sales Market Share by Application (2015-2020) 7 Europe Agricultural Animal Vaccine Market Facts & Figures7.1 Europe Agricultural Animal Vaccine Sales Market Share by Company (2015-2020)7.2 Europe Agricultural Animal Vaccine Sales Market Share by Type (2015-2020)7.3 Europe Agricultural Animal Vaccine Sales Market Share by Application (2015-2020) 8 China Agricultural Animal Vaccine Market Facts & Figures8.1 China Agricultural Animal Vaccine Sales Market Share by Company (2015-2020)8.2 China Agricultural Animal Vaccine Sales Market Share by Type (2015-2020)8.3 China Agricultural Animal Vaccine Sales Market Share by Application (2015-2020) 9 Japan Agricultural Animal Vaccine Market Facts & Figures9.1 Japan Agricultural Animal Vaccine Sales Market Share by Company (3015-3030)9.2 Japan Agricultural Animal Vaccine Sales Market Share by Type (2015-2020)9.3 Japan Agricultural Animal Vaccine Sales Market Share by Application (2015-2020) 10 Southeast Asia Agricultural Animal Vaccine Market Facts & Figures10.1 Southeast Asia Agricultural Animal Vaccine Sales Market Share by Company (2015-2020)10.2 Southeast Asia Agricultural Animal Vaccine Sales Market Share by Type (2015-2020)10.3 Southeast Asia Agricultural Animal Vaccine Sales Market Share by Application (2015-2020) 11 India Agricultural Animal Vaccine Market Facts & Figures11.1 India Agricultural Animal Vaccine Sales Market Share by Company (2015-2020)11.2 India Agricultural Animal Vaccine Sales Market Share by Type (2015-2020)11.3 India Agricultural Animal Vaccine Sales Market Share by Application (2015-2020) 12 Company Profiles and Key Figures in Agricultural Animal Vaccine Business12.1 Merck12.1.1 Merck Corporation Information12.1.2 Merck Business Overview12.1.3 Merck Agricultural Animal Vaccine Sales, Revenue and Gross Margin (2015-2020)12.1.4 Merck Agricultural Animal Vaccine Products Offered12.1.5 Merck Recent Development12.2 Zoetis12.2.1 Zoetis Corporation Information12.2.2 Zoetis Business Overview12.2.3 Zoetis Agricultural Animal Vaccine Sales, Revenue and Gross Margin (2015-2020)12.2.4 Zoetis Agricultural Animal Vaccine Products Offered12.2.5 Zoetis Recent Development12.3 Boehringer Ingelheim12.3.1 Boehringer Ingelheim Corporation Information12.3.2 Boehringer Ingelheim Business Overview12.3.3 Boehringer Ingelheim Agricultural Animal Vaccine Sales, Revenue and Gross Margin (2015-2020)12.3.4 Boehringer Ingelheim Agricultural Animal Vaccine Products Offered12.3.5 Boehringer Ingelheim Recent Development12.4 Ceva Corporate12.4.1 Ceva Corporate Corporation Information12.4.2 Ceva Corporate Business Overview12.4.3 Ceva Corporate Agricultural Animal Vaccine Sales, Revenue and Gross Margin (2015-2020)12.4.4 Ceva Corporate Agricultural Animal Vaccine Products Offered12.4.5 Ceva Corporate Recent Development12.5 HVRI12.5.1 HVRI Corporation Information12.5.2 HVRI Business Overview12.5.3 HVRI Agricultural Animal Vaccine Sales, Revenue and Gross Margin (2015-2020)12.5.4 HVRI Agricultural Animal Vaccine Products Offered12.5.5 HVRI Recent Development12.6 Ringpu Biology12.6.1 Ringpu Biology Corporation Information12.6.2 Ringpu Biology Business Overview12.6.3 Ringpu Biology Agricultural Animal Vaccine Sales, Revenue and Gross Margin (2015-2020)12.6.4 Ringpu Biology Agricultural Animal Vaccine Products Offered12.6.5 Ringpu Biology Recent Development12.7 Yebio Bioengineering12.7.1 Yebio Bioengineering Corporation Information12.7.2 Yebio Bioengineering Business Overview12.7.3 Yebio Bioengineering Agricultural Animal Vaccine Sales, Revenue and Gross Margin (2015-2020)12.7.4 Yebio Bioengineering Agricultural Animal Vaccine Products Offered12.7.5 Yebio Bioengineering Recent Development12.8 Guangdong Wenshi Dahuanong Biotechnology12.8.1 Guangdong Wenshi Dahuanong Biotechnology Corporation Information12.8.2 Guangdong Wenshi Dahuanong Biotechnology Business Overview12.8.3 Guangdong Wenshi Dahuanong Biotechnology Agricultural Animal Vaccine Sales, Revenue and Gross Margin (2015-2020)12.8.4 Guangdong Wenshi Dahuanong Biotechnology Agricultural Animal Vaccine Products Offered12.8.5 Guangdong Wenshi Dahuanong Biotechnology Recent Development12.9 Virbac12.9.1 Virbac Corporation Information12.9.2 Virbac Business Overview12.9.3 Virbac Agricultural Animal Vaccine Sales, Revenue and Gross Margin (2015-2020)12.9.4 Virbac Agricultural Animal Vaccine Products Offered12.9.5 Virbac Recent Development12.10 Jinyu Bio-Technology12.10.1 Jinyu Bio-Technology Corporation Information12.10.2 Jinyu Bio-Technology Business Overview12.10.3 Jinyu Bio-Technology Agricultural Animal Vaccine Sales, Revenue and Gross Margin (2015-2020)12.10.4 Jinyu Bio-Technology Agricultural Animal Vaccine Products Offered12.10.5 Jinyu Bio-Technology Recent Development12.11 ChengDu Tecbond12.11.1 ChengDu Tecbond Corporation Information12.11.2 ChengDu Tecbond Business Overview12.11.3 ChengDu Tecbond Agricultural Animal Vaccine Sales, Revenue and Gross Margin (2015-2020)12.11.4 ChengDu Tecbond Agricultural Animal Vaccine Products Offered12.11.5 ChengDu Tecbond Recent Development12.12 CHOONGANG VACCINE12.12.1 CHOONGANG VACCINE Corporation Information12.12.2 CHOONGANG VACCINE Business Overview12.12.3 CHOONGANG VACCINE Agricultural Animal Vaccine Sales, Revenue and Gross Margin (2015-2020)12.12.4 CHOONGANG VACCINE Agricultural Animal Vaccine Products Offered12.12.5 CHOONGANG VACCINE Recent Development12.13 FATRO12.13.1 FATRO Corporation Information12.13.2 FATRO Business Overview12.13.3 FATRO Agricultural Animal Vaccine Sales, Revenue and Gross Margin (2015-2020)12.13.4 FATRO Agricultural Animal Vaccine Products Offered12.13.5 FATRO Recent Development 13 Agricultural Animal Vaccine Manufacturing Cost Analysis13.1 Agricultural Animal Vaccine Key Raw Materials Analysis13.1.1 Key Raw Materials13.1.2 Key Raw Materials Price Trend13.1.3 Key Suppliers of Raw Materials13.2 Proportion of Manufacturing Cost Structure13.3 Manufacturing Process Analysis of Agricultural Animal Vaccine13.4 Agricultural Animal Vaccine Industrial Chain Analysis 14 Marketing Channel, Distributors and Customers14.1 Marketing Channel14.2 Agricultural Animal Vaccine Distributors List14.3 Agricultural Animal Vaccine Customers 15 Market Dynamics15.1 Agricultural Animal Vaccine Market Trends15.2 Agricultural Animal Vaccine Opportunities and Drivers15.3 Agricultural Animal Vaccine Market Challenges15.4 Agricultural Animal Vaccine Market Restraints15.5 Porters Five Forces Analysis 16 Research Findings and Conclusion 17 Appendix17.1 Research Methodology17.1.1 Methodology/Research Approach17.1.2 Data Source17.2 Author List17.3 Disclaimer

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

https://lionlowdown.com/

See the rest here:
Comprehensive Report on Agricultural Animal Vaccine Market 2021 | Trends, Growth Demand, Opportunities & Forecast To 2027 - LionLowdown

This article was written by Mo Ebrahimkhani, an associate professor of pathology and bioengineering at Pitt,for The Conversation. Faculty members and researchers who want to learn more about publishing in The Conversation canread about the process here.

Imagine if researchers could program stem cells, which have the potential to grow into all cell types in the body, so that they could generate an entire human organ. This would allow scientists to manufacture tissues for testing drugs and reduce the demand for transplant organs by having new ones grown directly from a patients cells.

Im a researcher working in this new fieldcalled synthetic biologyfocused on creating new biological parts and redesigning existing biological systems. In a new paper, my colleagues and I showed progress in one of the key challenges with lab-grown organsfiguring out the genes necessary to produce the variety of mature cells needed to construct a functioning liver.

Induced pluripotent stem cells, a subgroup of stem cells, are capable of producing cells that can build entire organs in the human body. But they can do this job only if they receive the right quantity of growth signals at the right time from their environment. If this happens, they eventually give rise to different cell types that can assemble and mature in the form of human organs and tissues.

The tissues researchers generate from pluripotent stem cells can provide a unique source for personalized medicine from transplantation to novel drug discovery.

But unfortunately, synthetic tissues from stem cells are not always suitable for transplant or drug testing because they contain unwanted cells from other tissues, or lack the tissue maturity and a complete network of blood vessels necessary for bringing oxygen and nutrients needed to nurture an organ. That is why having a framework to assess whether these lab-grown cells and tissues are doing their job, and how to make them more like human organs, is critical.

Inspired by this challenge, I was determined to establish a synthetic biology method to read and write, or program, tissue development. I am trying to do this using the genetic language of stem cells, similar to what is used by nature to form human organs.

I am a researcher specializing in synthetic biology and biological engineering at the Pittsburgh Liver Research Center and McGowan Institute for Regenerative Medicine, where the goals are to use engineering approaches to analyze and build novel biological systems and solve human health problems. My lab combines synthetic biology and regenerative medicine in a new field that strives to replace, regrow or repair diseased organs or tissues.

I chose to focus on growing new human livers because this organ is vital for controlling most levels of chemicalslike proteins or sugarin the blood. The liver also breaks down harmful chemicals and metabolizes many drugs in our body. But the liver tissue is also vulnerable and can be damaged and destroyed by many diseases, such as hepatitis or fatty liver disease. There is a shortage of donor organs, which limits liver transplantation.

To make synthetic organs and tissues, scientists need to be able to control stem cells so that they can form into different types of cells, such as liver cells and blood vessel cells. The goal is to mature these stem cells into miniorgans, or organoids, containing blood vessels and the correct adult cell types that would be found in a natural organ.

One way to orchestrate maturation of synthetic tissues is to determine the list of genes needed to induce a group of stem cells to grow, mature and evolve into a complete and functioning organ. To derive this list I worked with Patrick Cahan and Samira Kiani to first use computational analysis to identify genes involved in transforming a group of stem cells into a mature functioning liver. Then our team led by two of my studentsJeremy Velazquez and Ryan LeGrawused genetic engineering to alter specific genes we had identified and used them to help build and mature human liver tissues from stem cells.

The tissue is grown from a layer of genetically engineered stem cells in a petri dish. The function of genetic programs together with nutrients is to orchestrate formation of liver organoids over the course of 15 to 17 days.

I and my colleagues first compared the active genes in fetal liver organoids we had grown in the lab with those in adult human livers using a computational analysis to get a list of genes needed for driving fetal liver organoids to mature into adult organs.

We then used genetic engineering to tweak genesand the resulting proteinsthat the stem cells needed to mature further toward an adult liver. In the course of about 17 days we generated tinyseveral millimeters in widthbut more mature liver tissues with a range of cells typically found in livers in the third trimester of human pregnancies.

Like a mature human liver, these synthetic livers were able to store, synthesize and metabolize nutrients. Though our lab-grown livers were small, we are hopeful that we can scale them up in the future. While they share many similar features with adult livers, they arent perfect and our team still has work to do. For example, we still need to improve the capacity of the liver tissue to metabolize a variety of drugs. We also need to make it safer and more efficacious for eventual application in humans.

Our study demonstrates the ability of these lab livers to mature and develop a functional network of blood vessels in just two and a half weeks. We believe this approach can pave the path for the manufacture of other organs with vasculature via genetic programming.

The liver organoids provide several key features of an adult human liver such as production of key blood proteins and regulation of bilea chemical important for digestion of food.

When we implanted the lab-grown liver tissues into mice suffering from liver disease, it increased the life span. We named our organoids designer organoids, as they are generated via a genetic design.

Excerpt from:
Genetic Engineering Transformed Stem Cells Into Working Mini-Livers That Extended the Life of Mice With Liver Disease - UPJ Athletics

Jason Zhang, a 26-year-old bioengineering PhD graduate who joined a clinical trial of Moderna's COVID-19 vaccine, met with VICE World News in Seoul. Photo: Junhyup Kwon

To demonstrate their confidence in COVID-19 vaccination program, top American health officials including Dr. Anthony Fauci last month rolled up their sleeves and got their first dose of the Moderna vaccine on live television. Millions more in the United States and abroad are expected to do the same in the coming weeks to acquire protection against the virus that has killed more than 1.8 million people globally and wrecked economies.

The rollout is possible in part because of tens of thousands of people who volunteered to take part in fast-tracked trials to verify the effectiveness and safety of COVID-19 vaccines.

VICE World News spoke with Jason Zhang, a 26-year-old Chinese-American bioengineering PhD graduate who participated in Modernas clinical trial during the summer, to find out what it was like. Zhang, who is in South Korea on vacation and to learn Korean, also shared the moment during the trial when he went, Oh my god, do I need to go to the hospital?

VICE World News: How did you know about the clinical trial?Jason Zhang: I remember I was browsing through Facebook in June or July and saw the ads looking for participants in the Modernas COVID-19 vaccine clinical trial. And I was like: What is the harm in signing up and just putting in my basic information? After I signed up, around the end of July, I got a phone call from them asking me my availability for participating in the clinical trial. Back then, I was really excited to participate.

What were the reactions of your parents?Ive never been in a clinical trial before. My parents were very worried as Asian parents, or any parents in the world, do. I do remember that before participating in the trial, I talked to my family about the trial. My parents said: Why do you want to do the vaccine? Your life is very precious. Its okay if other people take the vaccine. We really want you to stay safe.

Why did you take part in the trial?One of the big things that motivated me to take part in the trial is how much the virus has affected everyones life and how disruptive it has been. I think its helping us move on.

One of the big things that motivated me to take part in the trial is how much the virus has affected everyones life. I think its helping us move on.

I did a lot of research into understanding what the vaccines are and what the side effects are. Researchers did publish a paper after conducting a first-in-human Phase 1 clinical trial in the New England Journal of Medicine. Because Im in the biology field, I decided to read up on the paper and they listed their side effects and what people experienced. So I thought that It wasnt anything super harmful and also was reading about how the vaccine works.

There are two major mRNA (messenger RNA) vaccines, one developed by Pfizer and the other by Moderna. (To trigger an immune response, many vaccines put a weakened or inactivated germ into our bodies. Not mRNA vaccines. Instead, they teach our cells how to make a proteinor even just a piece of a proteinthat triggers an immune response inside our bodies.)

I thought that it was both an exciting time to help make this new technology prove that its effective for infectious disease. And understanding how this technology has a lot of benefits in terms of cost, versatility, and safety.

I thought benefits outweigh the risks and thats why I decided to participate in the trial.

Were you not afraid of getting infected?In terms of getting infected, there were some vaccines in the past used as a dead virus. I believe the polio vaccine in the 1950s that used an inactivated form of the virus. And there were some manufacturing problems in the 1950s where some people actually got the polio virus instead of getting only the dead virus. And thats allowed for problems.

But this mRNA technology you are only getting genetic information and a genetic blueprint for one of the most important proteins of the coronavirus. So since youre only getting like one small portion out of maybe eleven proteins. I think on coronavirus that therefore youre not getting the whole thing. Theres a low possibility that youre going to get the live virus accidentally.

Understanding that technology made me more confident that Im not going to experience anything too bad, reading the paper in identifying the side effects, and also because Im relatively young that I didnt have to worry too much that Im going to have the severe symptoms from COVID-19.

Can you take us through the process?For both Moderna and Pfizer, you have to take two shots. For the Moderna one, I took the first shot in August and the second shot in September. And for both those appointments, they drew your basic vitals, blood pressures, height, and weight. They gave me a COVID-19 test, drew my blood, and then gave me an experimental vaccine. Note that there are two groups: there are some who get the control of the placebo and who actually get the vaccine.

So we dont know who gets the actual vaccine. But Im pretty sure that I got the actual vaccine because I got some COVID-like symptoms for a night after my second shot. I got the test vaccine and then after that I was in the waiting room for 30 minutes and for the week after getting the vaccine every day I had to put in my health information on a mobile app and also took my temperature. So that happened for both the first and second visit.

On the first visit, I didnt really feel that much besides maybe pain at the injection site a little bit. But at this after the second visit, after getting the second shot, I developed some COVID-like symptoms. So I felt like I had a fever but when I took my temperature I didnt really have a fever. I felt fatigued. And also the most prominent thing was that I got chills like my teeth were clattering and my body was so shaking. It wasnt like seizure level shaking but I felt a shaking and that lasted for about five minutes. At some point, I thought: Oh my god, do I need to go to the hospital?. But it only lasted for five minutes and after that night, I didnt feel any more COVID-like symptoms. So I thought I got the actual vaccine.

The most prominent thing was that I got chills like my teeth were clattering and my body was so shaking.

How did the vaccine change your life? Are you still wearing a face mask?First of all, vaccines are not 100 percent effective. Theres no drug that is 100 percent effective. But its still actually that vaccines have one of the highest effectiveness. Although media reports on the news that the Moderna vaccine has 94 to 95 percent effective, its still the preliminary data and theres five percent who are not effective. So even after I took the vaccine, I still wear a mask because Im not sure that Im actually immune to COVID-19.

Secondly, even if youre immune to COVID-19, you could still spread the virus. You wouldnt get sick yourself but you do have a possibility that you could still spread the virus. The likelihood of your spread probably decreases, but the data is still to be seen for that.

So I dont think my life has changed too much after getting the vaccine. I still wear a mask, try to do social distancing, and wash my hands a lot. I think all of those are necessary in order for us to get over COVID-19. Maybe I feel a little bit more confident to go outside than other average people. I do feel I have immunity but I also understand that even if I have immunity I can still spread it so I should still be very conscious of other people.

What do you think about the anti-vaccine movement?Ive definitely heard about the controversial people. I think the huge portion of the anti vaccine movement talks about how vaccines can cause autism. (Centers for Disease Control and Prevention says theres no link between vaccines and autism.)

As a scientist, our responsibility is to communicate these new technologies. I feel responsible to communicate the science and to educate people about how vaccines are made and how vaccines are going to affect you and the pros and cons of vaccines.

If you have questions about how vaccines work, read up on Google and trust reliable sources. Dont trust those crazy websites, and use medical journals for the most part. If you care about your health, you should take the time to read up about it. I encourage people to listen to scientists, not politicians, in order to get educated about vaccines.

I encourage people to listen to scientists, not politicians, in order to get educated about vaccines.

Since you came to South Korea, what have you discovered?Theres a definitely huge cultural difference in terms of how different countries are dealing with COVID-19. I think East Asian countries are generally doing very well in terms of having people wear a face mask and doing social distancing. And everyone is very conscientious of each other about cleanness. I would say 99 percent of people in South Korea wear masks while in the United States maybe like 60 or 70 percent of people wear masks. I think California has a higher percentage than lots of different places in the United States. That was a big difference is how much people are more careful and have diligence in terms of COVID-19.

Would you recommend your family to get vaccinated?Yes of course.

Interviews have been edited for length and clarity.

Follow Junhyup Kwon onTwitter. Find Jason Zhang on Twitter and Instagram.

Here is the original post:
What It Was Like to Participate in Modernas COVID-19 Vaccine Trial - VICE

Global Fumaric Acid Reports presents a pin-point breakdown of Fumaric Acid Industry based on type, applications, and research regions. The analytical study on production, demand & supply, the import-export scenario is studied in this report. Fumaric Acid Market consists of key players, manufacturing details, cost structures, sales margin, and market share. The forecast Fumaric Acid analysis presents revenue, market share and sales forecast from 2020 to 2027.

Get FREE Sample Copy (Including FULL TOC, Graphs, and Tables) of this report: https://perfectmarketinsights.com/report/global-fumaric-acid-market-by-sales-major-segments-regional-growth-rate-competitors-2020-2027-covid-19-outbreak-report#request-sample

The key players profiled in this Report are:

Changmao Biochemical EngineeringNIPPON SHOKUBAIChangzhou Yabang ChemicalBartek IngredientsSealong BiotechnologyXST BiologicalIsegenYantai Hengyuan BioengineeringSuzhou Youhe Science and TechnologyPolyntThirumalai ChemicalJiangsu Jiecheng BioengineeringFuso Chemicals

The research report studies the market in an exhaustive manner by explaining the key facets of the market that are foreseeable to have a countable stimulus on its developing extrapolations over the forecast period. This report Shares detailed information about the key factors (growth potential, opportunities, drivers, industrial assignments, and risks) affecting market growth. Due to the increasing globalization and digitization, there are new trends coming to the market every day.

Global Fumaric Acid Market Segmentation

Market Segmentation by Type:

Food gradeTechnical grade

Market Segmentation by Application:

Unsaturated PolyesterFood and beverage industryOthers

The Fumaric Acid market report also includes progressive analysis of the massive number of Various factors that are boosting or operating as well as regulating the Fumaric Acid industry growth. The variation of new ideas and accepting the newest trends are some of the reasons for any markets growth. This market research report gives a deep understanding of the regions where the market is impactful.

Top Key questions answered in this research report:

Enquire Before Buying : https://perfectmarketinsights.com/report/global-fumaric-acid-market-by-sales-major-segments-regional-growth-rate-competitors-2020-2027-covid-19-outbreak-report #inquiry-before-buying

Table of Contents

For more Information or Browse the complete report @ https://perfectmarketinsights.com/report/global-fumaric-acid-market-by-sales-major-segments-regional-growth-rate-competitors-2020-2027-covid-19-outbreak-report #table-of-contents

https://farmingsector.co.uk/

See the original post here:
Global Fumaric Acid Market Technology, Industry Growth, Product Type, Application, Distribution channel and Forecast to 2027 - Farming Sector

Two Caltech faculty members,Lihong WangandChanghuei Yang, have been named fellows of theNational Academy of Inventors(NAI). According to the NAI, election as a fellow is the highest professional distinction accorded to academic inventors who have demonstrated a prolific spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on quality of life, economic development and the welfare of society.

Wang, the Bren Professor of Medical Engineering and Electrical Engineering, is focused on biomedical imaging. His lab has developed photoacoustic imaging that allows researchers to see into biological tissues noninvasively, and to peer deeper into the body by nearly two orders of magnitude compared to conventional optical microscopy. Wang has been the recipient of a National Science Foundation CAREER award; and, from the National Institutes of Health (NIH), the FIRST, Directors Pioneer, Directors Transformative Research, and NIH/National Cancer Institute Outstanding Investigator awards.

Wang also received the C.E.K. Mees Medal from the Optical Society of America (OSA), a Technical Achievement Award from the Institute of Electrical and Electronics Engineers (IEEE), an IEEE Biomedical Engineering Award, SPIE Britton Chance Biomedical Optics Award, a Senior Prize from the International Photoacoustic and Photothermal Association, and an OSA Michael S. Feld Biophotonics Award for seminal contributions to photoacoustic tomography and light-speed imaging. He is a fellow of the American Association for the Advancement of Science, the American Institute for Medical and Biological Engineering, the Electromagnetics Academy, the International Academy of Medical and Biological Engineering, and the IEEE, OSA, and SPIE. He is a Foreign Fellow of the Chinese Optical Society. An honorary doctorate was conferred on him by Lund University, Sweden. In 2018, he was inducted into the National Academy of Engineering.

Yang is the Thomas G. Myers Professor of Electrical Engineering, Bioengineering, and Medical Engineering. The Yang lab at Caltech develops technologies aimed at transforming the conventional microscope so that it can be used for high-throughput, automated applications. He also works on the use of time-reversal techniques to undo the effect of tissue light scattering. Yang has received the NSF CAREER Award, Coulter Foundation Early Career Phase I and II Awards, and an NIH Directors New Innovator Award. He is a Coulter Fellow, an AIMBE Fellow, and an OSA Fellow.

Caltech alumni among the 2020 class of NAI fellows include William W. Bachovchin (PhD 77) of Tufts University, Gary A. Evans (MS 71, PhD 75) of Southern Methodist University, and Timothy M. Swager (PhD 88) of MIT. The NAIs 2020 class of fellows includes two Nobel Prize winners, 24 members of the National Academies of Sciences, Engineering, and/or Medicine, and six fellows of the American Academy of Arts and Sciences (AAAS). Collectively, the 2020 class includes the inventors of more than 4,700 U.S. patents.

In 2019, Caltech faculty members Peter B. Dervan, Bren Professor of Chemistry, and Julia A. Kornfield (BS 83), Elizabeth W. Gilloon Professor of Chemical Engineering,were named fellows of the NAI.

Get all the latest Pasadena news, more than 10 fresh stories daily, 7 days a week at 7 a.m.

Originally posted here:
Two Caltech Faculty Members Named to National Academy of Inventors - Pasadena Now

News Release

Monday, December 7, 2020

Online calculator computes costs of testing and offers strategies for preventing infections in schools and businesses.

It can be an enormous challenge for schools and businesses to determine how to establish an effective COVID-19 testing program, particularly with the multiple testing options now on the market. An innovative online tool funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), part of the National Institutes of Health, helps organizations choose a COVID-19 testing strategy that will work best for their specific needs. The COVID-19 Testing Impact Calculator is a free resource that shows how different approaches to testing and other mitigation measures, such as mask use, can curb the spread of the virus in any organization. It is the first online tool in the nation to provide schools and businesses with clear guidance on risk-reducing behaviors and testing to help them stay open safely.

A team led by the Consortia for Improving Medicine with Innovation and Technology (CIMIT) at Massachusetts General Hospital, Boston, and researchers at the Massachusetts Institute of Technology (MIT), Cambridge, developed the tool to model the costs and benefits of COVID-19 testing strategies for individual organizations. The team developed their mathematical model and calculator as part of NIHs Rapid Acceleration of Diagnostics (RADx) Tech program. The calculator is simple--a user enters a few specifics about their site and the tool produces customized scenarios for surveillance testing. The tool models four different COVID-19 testing methods, including onsite and lab-based, and calculates the number of people to test each day. It shows the estimated cost of each testing option and outlines the tradeoffs in the speed and accuracy of each kind of test.

The NIH RADx initiative has enabled innovation and growth in the creation of new, rapid COVID-19 testing technologies, said Bruce J. Tromberg, Ph.D., director of NIBIB and lead for the RADx Tech program.Using this tool, school administrators and business owners can quickly evaluate the cost and performance of different tests to help find the best match for their unique organization.

The COVID-19 Testing Impact Calculator also shows how other Centers for Disease Control and Prevention-recommended countermeasures, such as masks, contact tracing and social distancing, can work in concert with testing to keep people safe. Users enter which of these measures are in place in their organization and the tool integrates this information to produce testing recommendations. By adjusting these entries, users get a startling demonstration of how implementing simple countermeasures can drastically reduce their testing costs. For example, for a site that allows mask-less activities such as meetings or dining, reducing the group size on the calculator from 12 to six cuts the cost of the recommended testing strategy by more than half. Thus, the tool can inform leaders about how implementing these practices in addition to testing can keep their school or business open safely and with less expense.

Co-developer of the tool, Anette (Peko) Hosoi, Ph.D., is associate dean of engineering and the Neil and Jane Pappalardo Professor of Mechanical Engineering at MIT. She also is an affiliate of the universitys Institute for Data, Systems, and Society (IDSS), where students and researchers combine cutting-edge data analysis with social science methodology to tackle pressing societal challenges like the coronavirus pandemic.

A false dichotomy is often perpetuated that we must either stop COVID or reopen the economy, said Hosoi. But we know a lot now about how this disease spreads and the answer is not an either/or proposition. We know what kinds of measures are necessary to keep things running and mitigate the spread while operating maybe not under normal conditions, but certainly under functional conditions.

Co-developer Paul Tessier, Ph.D., is product development director at CIMIT, the RADx Tech coordinating center. The calculator is a major enabler for test-technologies being developed, commercialized and deployed with help from the RADx Tech program, Tessier said. He explained that implementing a testing program carries weighty considerations, including cost and number of testing instruments, arranging for test takers, and determining the optimal frequency for testing. We are excited to join forces with MITs IDSS to advance a decision-making tool for operating safely.

The COVID-19 Testing Impact Calculator is at http://www.whentotest.org.

This project was fundedbythe National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, throughthe NIH RADxInitiative via grant #U54EB015408 and contracts #75N92020P00132 and #75N92020P00171.

About the Rapid Acceleration of Diagnostics (RADxSM) initiative:The RADx initiative was launched on April 29, 2020, to speed innovation in the development, commercialization, and implementation of technologies for COVID-19 testing. The initiative has four programs: RADx Tech, RADx Advanced Technology Platforms, RADx Underserved Populations and RADx Radical. It leverages the existing NIH Point-of-Care Technology Research Network. The RADx initiative partners with federal agencies, including the Office of the Assistant Secretary of Health, Department of Defense, the Biomedical Advanced Research and Development Authority, and U.S. Food and Drug Administration. Learn more about the RADx initiative and its programs:https://www.nih.gov/radx.

About the National Institute of Biomedical Imaging and Bioengineering (NIBIB):NIBIBs mission is to improve health by leading the development and accelerating the application of biomedical technologies. The Institute is committed to integrating the physical and engineering sciences with the life sciences to advance basic research and medical care. NIBIB supports emerging technology research and development within its internal laboratories and through grants, collaborations, and training. More information is available at the NIBIB website:https://www.nibib.nih.gov.

About the National Institutes of Health (NIH):NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.

NIHTurning Discovery Into Health

###

Read this article:
funded tool helps organizations plan COVID-19 testing - National Institutes of Health

The Clemson University CLIA Lab is now offering COVID-19 PCR saliva testing to members of the Clemson community thanks in part to a grant that allowed for expansion provided to the lab from the South Carolina General Assembly. Originally only available to Clemson University Students, Faculty and Staff, the free testing is now accessible to all members of the greater Clemson community in an effort to slow the spread of COVID-19. "I think our goal was to always expand and provide resources for the community," said Clemson University professor of bioengineering and director of the CLIA Lab Delphine Dean. "Now we've opened it up so that folks in the community can come and get tested for free. The university is not it's own little bubble island. We are in the community and it is important for everyone to have access to cheap and accurate testing."The saliva testing is being offered weekdays from 10 a.m. to 4 p.m. at Memorial Stadium and consist of a saliva collection. Test takers that spoke to WYFF News 4 today said the process only took 3 to 5 minutes from entry to exit. "It was easy. Easy to get a QR code, easy to register, easy to park and walk up," Clemson community member Kristina Nelson said after she was tested at Memorial Stadium. "It was very very simple. I was done and in and out in 3 minutes I'm sure.""We thought while it was being offered, why not," Clemson community member Joy Dvoloznak said. "It is an opportunity to get tested and see if anything is wrong basically."The tubes are then taken to the CLIA Lab and analyzed, searching for traces of COVID-19. Dean adds that although the results can be turned around in 6-8 hours in most cases, this is not a "rapid" COVID-19 test and therefore does not have the lack of accuracy that some rapid test methods have. To register for a Clemson University COVID-19 saliva test, click here.

The Clemson University CLIA Lab is now offering COVID-19 PCR saliva testing to members of the Clemson community thanks in part to a grant that allowed for expansion provided to the lab from the South Carolina General Assembly.

Originally only available to Clemson University Students, Faculty and Staff, the free testing is now accessible to all members of the greater Clemson community in an effort to slow the spread of COVID-19.

"I think our goal was to always expand and provide resources for the community," said Clemson University professor of bioengineering and director of the CLIA Lab Delphine Dean. "Now we've opened it up so that folks in the community can come and get tested for free. The university is not it's own little bubble island. We are in the community and it is important for everyone to have access to cheap and accurate testing."

The saliva testing is being offered weekdays from 10 a.m. to 4 p.m. at Memorial Stadium and consist of a saliva collection. Test takers that spoke to WYFF News 4 today said the process only took 3 to 5 minutes from entry to exit.

"It was easy. Easy to get a QR code, easy to register, easy to park and walk up," Clemson community member Kristina Nelson said after she was tested at Memorial Stadium. "It was very very simple. I was done and in and out in 3 minutes I'm sure."

"We thought while it was being offered, why not," Clemson community member Joy Dvoloznak said. "It is an opportunity to get tested and see if anything is wrong basically."

The tubes are then taken to the CLIA Lab and analyzed, searching for traces of COVID-19. Dean adds that although the results can be turned around in 6-8 hours in most cases, this is not a "rapid" COVID-19 test and therefore does not have the lack of accuracy that some rapid test methods have.

To register for a Clemson University COVID-19 saliva test, click here.

See the original post here:
Clemson University CLIA Lab offers free COVID-19 testing to community members - WYFF4 Greenville

Various diagnostic techniques can be used for sensing the RNA of SARS-CoV-2. Credit: Saadet Alpdagtas and Elif Ilhan

Different diagnostic techniques are appropriate at different stages of coronavirus infection. Using the right one is crucial for rapid diagnosis to help end the pandemic.

Until a vaccine is available, curbing the coronavirus pandemic relies heavily on how quickly a potentially exposed individual can be tested and quarantined. However, the current diagnostic techniques vary in reliability and relevance, so an understanding of which test is most appropriate for a given circumstance is necessary to avoid false reports.

Researchers from Van Yuzuncu Yil University, Marmara University, Yildiz Technical University, and Istanbul Yeni Yuzyil University evaluated the available diagnostic techniques and determined key steps required for better testing moving forward. They present their findings in the journalAPL Bioengineering, from AIP Publishing.

Rapid diagnosis and rapid isolation are the key factors for prevention of the pandemic, said Oguzhan Gunduz, one of the authors.

Laboratory tests that target the viruss genes known as real-time reverse transcription-polymerase chain reaction assays are currently the gold standard for testing. But according to the Food and Drug Administration, these could give false negatives.

These tests depend on the presence of antibodies, which may not have yet been developed in the early stages of infection. Since different antibodies appear at different stages, diagnostic tests must be chosen to target the appropriate immune response based on when an individual is believed to have been infected.

There is not any available single test for the entire stage of the disease, Gunduz said. However, I think it may be possible to detect the attack at any stage of the disease with nano-based sensor technologies.

The group emphasizes point-of-care testing as an urgent objective. These types of tests would help detect the virus on site without the need for laboratory equipment or specialized personnel, eliminating or reducing the wait time between testing and obtaining results.

A quite sensitive test that can measure the existent tiny number of viral particles, or any parameter related to the particle weight, structure, charge, diameter can provide rapid and early diagnosis, said Gunduz.

When asked about the potential for a more comfortable testing method, he stressed that this depends on the sampling method and its sensitivity. A fingertip blood test or a saliva test could potentially be underway, though these have their own drawbacks.

There are such tests, but they come up with accuracy and specificity issues, Gunduz said.

Reference: Evaluation of current diagnostic methods for COVID-19 by Saadet Alpdagtas, Elif Ilhan, Ebru Uysal, Mustafa Sengor, Cem Blent stndag and Oguzhan Gunduz, 1 December 2020, AIP Bioengineering.DOI: 10.1063/5.0021554

More:
There Many Different COVID-19 Tests Which One to Choose? - SciTechDaily

Last years Year of Creativity involved supporting dynamic art projects such as the flash mob at the Cathedral of Learning. But with this years Year of Engagement lacking the ability to engage in person with the Pitt community, project members had to get creative with their initiatives.

The Year of Engagement is this years edition of Pitts Year of series, headed by the Provosts office. This years theme aims to confront the worlds biggest challenges and mobilize towards a better, more equitable and just society for all, according to Kathy Humphrey, the senior vice chancellor for engagement.

The Year of Engagement steering committee helps make this happen. The committee, which consists of 28 members from across the University community, provides funding to projects it thinks will help strengthen the connections between people and create a more engaged Pitt. More than $22,000 in grants have been distributed to nine different projects so far, all of which have plans for new engagement initiatives for the University.

Each of the grant winners are members of the Pitt community, ranging from a librarian to a theater arts professor. Jorge Jimenez, a pre-doctoral fellow in the bioengineering department, is one of the individuals who received funding for a proposal. Jimenez said during a recent event about projects related to the year that he plans to teach computer engineering to Latinx communities to help kids learn how to design using computer software.

I partnered with people who I met from the Disrespecting The Border mural, Jimenez said. To come up with how to take engineering and art and community engagement through the lens of public health experts. To work together to teach kids to design using engineering software We are going to host three virtual workshops that teach the cultural impact of technology in Latin America.

Lynn Kawaratani, the engagement manager at the University Center for International Studies, proposed a project focused on making murals throughout Pittsburgh. Kawaratani said during a recent event about projects related to the year that she finds it interesting that the Year of Engagement coincided with the pandemic.

Its surprising that the year of engagement is this year, Kawaratani said. Its almost like all these pieces are coming together. As terrible as this year has been, theres all these opportunities we can seize upon in this crisis.

Cedric Humphrey, the Student Government Board executive vice president, said when he and fellow SGB member Kathryn Fleisher were coming up with the theme of the year, they werent expecting or thinking about a global pandemic. Instead, he said they picked this year because it is an election year.

There was no way that we couldve known that COVID-19 would impact our year back when we started planning, but we knew it would be a busy year with the presidential election and the census, and now with the renewed social justice movement, Humphrey said. We know that a lot of engagement work is already happening at Pitt, but now, we want to put a spotlight on it.

The Year of Engagement recently hosted two virtual coffee events to honor the nine grant recipients and to give them each the opportunity to discuss their projects with the Pitt community.

In addition to the coffee events, the committee also organized a 14-day social media campaign in the beginning of the semester. The campaign challenged students to respond to daily prompts on Twitter using the #PittEngage hashtag. Some prompts asked participants to answer questions about Pittsburgh-themed topics, take the Harvard implicit bias test and share an act of kindness they did that day.

Whoevers tweet received the most likes would be the winner of the days challenge. Winners were given a choice between receiving Pitt gear or donating that money to youth programs at the Universitys Community Engagement Centers in the Hill District and Homewood.

Steven Abramowitch, a committee member and bioengineering professor, said the vast majority of winners chose to donate the funds more than $3,000 in all. He said the social media challenge reached 23 different units responsibility centers, academic departments, student organizations around Pitt, more than any other campaign has.

Johanna Siegel, a senior bioengineering major, won an individual award and one with her sorority, Phi Sigma Rho. Siegel said she got involved in the social media challenge along with her sorority to raise money for her sororitys philanthropic work.

This is my first year [taking part in these events], and I mostly decided to do it to benefit Phi Rho, Siegel said. We voted as an organization to donate the money, which I thought was really nice.

Siegel said she found out about the year of engagement through an email from Abramowitch, her academic adviser.

He was getting the word out, Siegel said. I was like, whoa, this is really cool because if you win, you can earn money for your organization that you can then choose to use for your organization or donate.

According to Abramowitch, the Year of Engagement team wants to highlight those who are doing good around Pittsburgh and campus.

We had relatively good participation in [the social media challenge], Abramowitch said. And overall, I thought, given the pandemic and everything and the inability for us to meet in person.

Abramowitch said he has been seeing a lot of anxiety this year with the COVID-19 pandemic and wants to try to use the Year of Engagement to alleviate some of the stress that students have been facing by putting out positive messages of what people around the community have been doing in their fields and for the Pitt community.

Theres just been a lot of frustration, anxiety and stress going on, Abramowitch said. And so what we want to do is we want to start focusing on positive messages and really provide examples of student organizations and other departments around Pitt who are just doing outstanding engagement and really highlighting those efforts.

Abramowitch said he finds it hard to plan events this year since they are all virtual and he sees a lot of burnout from students from doing all their classes online. But he said the team this year has been working hard to plan events that will get the Pitt community engaged.

I think a lot of the time when people think of engagement, they think of in-person types of events and activities, Abramowitch said. And certainly weve not been able to do really any of those. So weve really had to modify what it means to be engaged and how to engage and how to get people enthusiastic about engaging.

Read the rest here:
Year of Engagement awards funding to proposals, hosts social media challenge - University of Pittsburgh The Pitt News

The research, carried out using a wearable cuff, provides a new method for monitoring movements in babies, and new insights into how babies' reflexes - like kicking - develop. These insights and the cuff could also be used to spot early signs of motor disorders such as cerebral palsy.

The research, published today in Science Advances, was done in collaboration with the Santa Lucia Foundation and Casilino Hospital in Rome.

Babies start kicking as foetuses in the womb and continue to kick instinctively until they are around four months old. The kicks mainly involve spinal neurons, as do protective reflexes found in adults like swiftly removing a hand from heat. However, not much is known about how the movement is generated on a neuronal level because detailed analysis of individual nerve cells has previously not been possible without surgery.

Now, Imperial and Santa Lucia Foundation researchers have developed a non-invasive cuff that slips onto freely kicking babies' legs to monitor neuronal activity without the need for surgery. The system decodes the electrical field potentials on the body surface and mathematically reverses their generation process, thus identifying the neural activity of the spinal cord.

Using the cuff the researchers found that, unlike fast leg movements in adults, babies' kicks are generated by the neurons in the spinal cord firing at the exact same time. This 'extreme synchronisation', the researchers say, increases the force generated by muscles attached to the nerves - which explains why babies' kicks can be relatively hard and fast even though their muscles are still weak and slow.

The researchers say these results, which are published today in Science Advances, are crucially important for our understanding of the development of spinal neural networks.

Lead author Professor Dario Farina of Imperial's Department of Bioengineering said: "This is a fundamental discovery of how foetuses and babies develop. The findings, and the new technology that helped us make the discovery, could help monitor development in babies and spot signs of motor disorders like cerebral palsy early on."

Co-senior author Professor Francesco Lacquaniti of the University of Rome Tor Vergata and Santa Lucia Foundation added: "The new monitoring cuff is an exciting technological achievement that could help us monitor babies for signs of motor problems so that we can diagnose and treat them early."

Fundamental discovery

The cuff attaches to the lower leg and contains a neuromuscular interface which records the electrical signals on the skin. It then decodes these signals and their timings to work out which spinal cord neurons are firing, and how quickly.

They tested the cuff on four freely kicking healthy babies aged two to 14 days old, and on twelve adult men doing various movements.

They found that in babies, all neurons fire closely in time to generate a kick, whereas there was significantly less synchronisation in the adult individuals.

Professor Farina said: "Generating fast movements is vital for human survival and health. Babies can already kick very fast just days after birth, and now we know that they do so using all spinal nerves at the same time."

Evolutionary advantage?

Baby kicks are thought to strengthen leg muscles and prepare the infant to roll over and eventually learn to walk. However, the researchers say their findings could suggest another advantage.

Dr Del Vecchio, the first author of the study from Professor Farina's research group, said: "The strength and speed of the kicking, as well as the synchronisation of nerve activity, could suggest that kicking has a more immediate protective advantage for babies. Perhaps babies developed such strong kicks through evolution to avoid potential dangers like predators."

The researchers are now looking into monitoring spinal neurons in babies with motor disorders like cerebral palsy. They hope their research could help to develop new clinical markers for the early diagnoses of these types of disorders.

Read more:
New non-invasive technology could spot early signs of motor disorders in babies - Science Codex

Bacillus Subtilis Marketreport includes (6 Year Forecast 2020-2026) an extensive analysis of competition by top manufacturers(Bayer AG, BASF SE, Jocanima Corporation, Tonglu Huifeng, Kernel Bio-tech, Wuhan Natures Favour Bioengineering Co., Ltd., Real IPM, ECOT China, and Qunlin.). It also offers in-intensity insight of the Bacillus Subtilis industry masking all vital parameters along with, Drivers, Market Trends, Market Dynamics, Opportunities, Competitive Landscape, Price and Gross Margin, Bacillus Subtilis Market Share via Region, New Challenge Feasibility Evaluation, Analysis and Guidelines on New mission Investment.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Bacillus Subtilis Market @https://www.coherentmarketinsights.com/insight/request-sample/1253

Manufacturing Cost Analysis of Bacillus Subtilis Market:Bacillus Subtilis Significant Raw Supplies Analysis, Vital Raw Materials, Price Trend of Key Raw Materials, Key Suppliers of Raw Materials, Market Concentration Rate of Raw Materials, Proportion of Manufacturing Price Structure, Raw Materials, Labour Cost, Industrial Expenses., Manufacturing Development Analysis,Bacillus Subtilis Market Drivers and Opportunities.

Scope Of this report:

Global Bacillus Subtilis Market Taxonomy:

By Product Type:

By Application:

Make An Enquiry for Discount Before Buying The Report:https://www.coherentmarketinsights.com/insight/talk-to-analyst/1253

Table of Contents

Market Overview:In this section, the authors of the report provide an overview of products offered in the global Bacillus Subtilis market, market scope, consumption comparison by application, production growth rate comparison by type, highlights of geographical analysis in Bacillus Subtilis market, and a glimpse of market sizing forecast.

Manufacturing Cost Analysis:It includes manufacturing cost structure analysis, key raw material analysis, Bacillus Subtilis industrial chain analysis, and manufacturing process analysis.

Company Profiling:Here, the analysts have profiled leading players of the global Bacillus Subtilis market on the basis of different factors such as markets served, market share, gross margin, price, production, and revenue.

Analysis by Application:The Bacillus Subtilis report sheds light on the consumption growth rate and consumption market share of all of the applications studied.

Bacillus Subtilis Consumption by Region:Consumption of all regional markets studied in the Bacillus Subtilis report is analysed here. The review period considered is 2014-2019.

Bacillus Subtilis Production by Region:It includes gross margin, production, price, production growth rate, and revenue of all regional markets between 2014 and 2019.

Competition by Manufacturer:It includes production share, revenue share, and average price by manufacturers. Bacillus Subtilis market analysts have also discussed the products, areas served, and production sites of manufacturers and current as well as future competitive situations and trends.

*If you need anything more than these then let us know and we will prepare the report according to your requirement.

Contact For Any Query or to Get Customized Report:https://www.coherentmarketinsights.com/insight/request-customization/1253

Contact Us:Mr. ShahCoherent Market Insights1001 4th Ave,#3200Seattle, WA 98154Tel: +1-206-701-6702Email:[emailprotected]Visit our blog:http://bit.ly/lazy

Read the original:
Bacillus Subtilis Market | Coronavirus (COVID-19) Impact Analysis with Key Business Opportunities, Key Strategies and Insight Drivers 2020-2026 - The...

CHAMPAIGN, Ill. Three faculty members at the University of Illinois at Urbana-Champaign have been named to the 2020 Clarivate Analytics Highly Cited Researchers list.

The list recognizes leading researchers in the sciences and social sciences from around the world. It is based on an analysis of journal article publication and citation data, an objective measure of a researchers influence, from 2009-2019.

The highly cited Illinois researchers this year are: materials science and engineering professor Axel Hoffmann, crop sciences and plant biology professor Stephen Long, and plant biology professor Donald Ort.

Axel Hoffmann

Photo by L. Brian Stauffer

Edit embedded media in the Files Tab and re-insert as needed.

Hoffmann is a Founder Professor in materials science and engineering and a member of the Materials Research Laboratory. His research focuses on topics related to magnetism, such as spin transport, magnetization dynamics and biomedical applications. His work on spin Hall effects has contributed to the development of spintronics, electronic devices that harness electron spin for faster and more efficient computing. Hoffmann is a Fellow of the American Vacuum Society, the American Physical Society and the Institute of Electrical and Electronics Engineers.

Stephen Long

Photo by L. Brian Stauffer

Edit embedded media in the Files Tab and re-insert as needed.

Long is the Stanley O. Ikenberry Chair of Crop Sciences and Plant Biology. He uses computational and bioengineering approaches to improve photosynthetic efficiency and works to address the effects of climate change on crop yields. He was elected a Fellow of the Royal Society of London in 2013 and has been recognized as a highly cited researcher every year since 2005. He directs Realizing Increased Photosynthetic Efficiency, a multinational project supported by the Bill & Melinda Gates Foundation, the Foundation for Food and Agricultural Research, and the U.K. Foreign Commonwealth and Development Office. He is an affiliate of the Carl R. Woese Institute for Genomic Biology at the U. of I.

Donald Ort

Photo by L. Brian Stauffer

Edit embedded media in the Files Tab and re-insert as needed.

Ort is the Robert Emerson Professor of Plant Biology and Crop Sciences at Illinois. His research focuses on improving photosynthesis and addresses crop responses to global change factors including increases in atmospheric carbon dioxide and temperature. He leads the Genomic Ecology of Global Change theme in the IGB and was elected to the National Academy of Sciences in 2017.

See original here:
Three Illinois scientists rank among world's most influential | Illinois - University of Illinois News

The research study of the global Fumaric Acid market provides the market size information and market trends along with the factors and parameters impacting it in both the short and long term. The report ensures a 360-degree assessment, bringing out the complete key insights of the industry. These insights help the business decision-makers to make better business plans and informed decisions for the future business. In addition, the study helps the venture capitalist in understanding the companies better and take informed decisions.

The Fumaric Acid market research report provides essential statistics on the market position of the Fumaric Acid manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. The report provides a basic summary of theFumaric Acid industry including its definition, applications and manufacturing technology. The report presents the company profile, product specifications, capacity, production value, and market shares for key vendors.

The overall market is split by the company, by country, and by application/type for the competitive landscape analysis. The report estimates market development trends of Fumaric Acid industry. Analysis of upstream raw materials, downstream demand and current market dynamics is also carried out. The Fumaric Acid market report makes some important proposals for a new project of Fumaric Acid Industry before evaluating its feasibility.

Request for a sample copy of the report to get extensive insights into Fumaric Acid market @https://www.in4research.com/sample-request/2203

Key segments covered in Fumaric Acid market report: Major key companies, product type segment, end use/application segment and geography segment.

The information for each competitor includes:

Company segment, the report includes global key players of Fumaric Acid as well as some small players:

For product type segment, this report listed the main product type of Fumaric Acid market

For end use/application segment, this report focuses on the status and outlook for key applications. End users are also listed.

Any Questions/Queries or need help? Speak with our analyst:https://www.in4research.com/speak-to-analyst/2203

This report covers the following regions:

Key Questions Answered in the Report:

We also can offer a customized report to fulfill the special requirements of our clients. Regional and Countries report can be provided as well.

Ask for more details or request custom reports from our industry experts @https://www.in4research.com/customization/2203

Go here to see the original:
Fumaric Acid Market Trends Forecast Analysis by Manufacturers, Regions, Type and Application to 2026 - Eurowire

Dataintelo, one of the worlds prominent market research firms has announced a novel report on the LED Lighting for Horticulture Application market. The report is integrated with imperative insights on the market which will support the clients to make precise business decisions. This research will help both existing and new aspirants for Global LED Lighting for Horticulture Application Market to figure out and study market requirements, market size, and competition. The report incorporates data regarding the supply and demand situation, the competitive scenario, and the challenges for market growth, market opportunities, and the threats encountered by key players during the forecast period of 2020-2027.

Request a sample before buying this report @ https://dataintelo.com/request-sample/?reportId=90213

Impact of COVID-19

The report also incorporates the impact of the ongoing global crisis i.e. COVID-19 on the LED Lighting for Horticulture Application market and explains how the future is going to unfold for the global market. The report also provides an analysis of the effects of the pandemic on the global economy. The outbreak has directly affected production and demand disrupted the demand and supply chain. The report also computes the financial impact on firms and financial markets. Dataintelo has accumulated insights from various delegates of the industry and got involved in the primary and secondary research to offer the clients data & strategies to combat the market challenges during and after the COVID-19 pandemic.

Benefits of buying the report:

Industry experts and research analysts have worked extensively to fabricate the research report which will give that extra edge to your business in the competitive market. The market research report can be customized as per you and your needs. This means that Dataintelo can cover a particular product, application, or can offer a detailed analysis in the report. You can also buy a separate report for a specific region.

You can buy the complete report @ https://dataintelo.com/checkout/?reportId=90213

Some of the major companies that are covered in this report:

CreeFluence BioengineeringHeliospectraHubbell LightingIllumitexKessil LightingLemnis OreonLumiGrowOsram SylvaniaSmart Grow Technologies

*Note: Additional companies can be included on request

The market scenario is likely to be fairly competitive. To analyze any market with simplicity the market is fragmented into the following segments:

By Application:

Commercial greenhouseIndoor and vertical farming

By Type:

LED LampLED Luminaire

By Geographical Regions

Asia Pacific: China, Japan, India, and Rest of Asia PacificEurope: Germany, the UK, France, and Rest of EuropeNorth America: The US, Mexico, and CanadaLatin America: Brazil and Rest of Latin AmericaMiddle East & Africa: GCC Countries and Rest of Middle East & Africa

Segmenting the market into smaller components helps in analyzing the dynamics of the market with more clarity. Another key component that is integrated into the report is the regional analysis to assess the global presence of the LED Lighting for Horticulture Application market. You can also opt for a yearly subscription of all the updates on the LED Lighting for Horticulture Application market.

Below is the TOC of the report:

Executive Summary

Assumptions and Acronyms Used

Research Methodology

LED Lighting for Horticulture Application Market Overview

Global LED Lighting for Horticulture Application Market Analysis and Forecast by Type

Global LED Lighting for Horticulture Application Market Analysis and Forecast by Application

Global LED Lighting for Horticulture Application Market Analysis and Forecast by Sales Channel

Global LED Lighting for Horticulture Application Market Analysis and Forecast by Region

North America LED Lighting for Horticulture Application Market Analysis and Forecast

Latin America LED Lighting for Horticulture Application Market Analysis and Forecast

Europe LED Lighting for Horticulture Application Market Analysis and Forecast

Asia Pacific LED Lighting for Horticulture Application Market Analysis and Forecast

Asia Pacific LED Lighting for Horticulture Application Market Size and Volume Forecast by Application

Middle East & Africa LED Lighting for Horticulture Application Market Analysis and Forecast

Competition Landscape

If you have any questions on this report, feel free to reach us! @ https://dataintelo.com/enquiry-before-buying/?reportId=90213

About Dataintelo:

Dataintelo has a vast experience in making customized market research reports in a number of industry verticals. Our motto is to provide complete client satisfaction. We cover in-depth market analysis, which consists of stipulating lucrative business strategies, especially for the new entrants and the emerging players of the market. We make sure that each report goes through intensive primary, secondary research, interviews, and consumer surveys before final dispatch.

We invest in our analysts to ensure that we have a full roster of experience and expertise in any field we cover. Our team members are selected for stellar academic records, specializations in technical fields, and exceptional analytical and communication skills. We also offer ongoing training and knowledge sharing to keep our analysts tapped into industry best practices and loaded with information.

Contact Info: Name: Alex MathewsAddress: 500 East E Street, Ontario, CA 91764, United States.Phone No: USA: +1 909 545 6473Email: [emailprotected]Website: https://dataintelo

Read more from the original source:
Impact Of Covid-19 On LED Lighting for Horticulture Application Market Is Slated To Grow Rapidly In The Forthcoming Years With Key Players Cree,...

The answer is largely in the eye of the beholder, but for many people, its one that is professionally rewarding and offers a high annual salary.

The medical field blends the best of both worlds. Year after year, when reports on the highest-paying occupations are released, the health care industry which encompasses medical and biological disciplines is routinely at the top of the list.

However, considering the fact that health care represents approximately one-sixth of the United States economy, there are a host of potential branches of medicine to consider.

One of the more popular career arcs that more people are pursuing is bioengineering. Biomedical engineers work for a variety of employers, including colleges and universities, pharmaceutical manufacturers, engineering and life sciences firms, companies in research and development, as well as medical devices and supplies manufacturing organizations. Their skills are in high demand because their experience combines the technical know-how that engineers are known for, with the expertise, professionalism and capabilities medical researchers bring to the table.

Whats more, the average bioengineering salary is quite lucrative even at entry level. With an online Master of Science in Engineering with a specialization in Bioengineering through the University of California, Riverside, you can set yourself up for success in this branch of health care and find a high-paying position upon graduation, as the job outlook for biomedical engineering is better than the national average. Indeed, according to the U.S. Bureau of Labor Statistics, an estimated 20,000 new biomedical engineering jobs are poised to open up between 2016 and 2026 nationwide.

All this being said, the question remains: What is the typical bioengineering salary like in terms of actual numbers?

Before answering the bioengineer salary question, its helpful to get a better understanding of what bioengineers work is like. The Bureau of Labor Statistics effectively summarizes what they do on a day-to-day basis. In general, bioengineers design, install, evaluate and create the machines and medical devices that physicians use to treat and diagnose patients. Because so much of their expertise involves biomechanics, they must be proficient in mechanical engineering. Several of the classes in the online Master of Science in Engineering program revolve around the branch of study, including Introduction to Microelectromechanical Systems, Sustainable Product Design as well as Design and Analysis of Engineering Experiments, each of which is a four credit-hour course. As youll discover, many of the courses within bioengineering have some overlap with similar branches, such as environmental engineering.

Despite being different professions, each uses many of the same problem-solving skills to achieve results, with the ultimate goal of bettering the publics overall health and well-being through the use of state-of-the-art equipment, software and intelligent devices. Their capabilities in these capacities in addition to their expertise obtained through schooling and on-the-job experience are among the main reasons why bioengineers, in particular, are so well compensated.

Most roles in health care require several years of schooling. Medical scientists are a classic example, who typically need a medical degree in addition to their undergraduate. The role of bioengineer is a rare exception. A bachelors degree is the typical level of education needed for entry-level professionals. However, a number of biomedical engineering jobs require a masters degree.

Although there are always exceptions, the more education you obtain, the higher the potential reward. Among all professions, individuals with a professional degree in 2017 had an average salary that paid approximately $700 more per week than those with only a bachelors degree, according to the most recent statistics available from the Bureau of Labor Statistics. Those with a masters degree earned roughly $300 more.

All this being said, what can you expect to earn with a bioengineering salary? As is so often the case, it depends on several factors, including who you ask, the type of bioengineer job thats available, location and years of experience.

For instance, in 2018, the median bioengineer salary was $88,550 per year, according to BLS analysis. That translates to an hourly rate of roughly $42.50.

Speak to bioengineers in research and development, though, and they may tell you a different salary story. In May 2018 the most recent month for which complete government data was available bioengineers earned a median of $93,250. Those in medical equipment and supplies manufacturing made less at $83,450 per year, with biomedical engineers employed at colleges, universities and other academic institutions earning $69,100. That is still higher than what the average household receives in annual wages.

Meanwhile, bioengineers in navigational, measuring, electromedical and control instruments manufacturing saw the highest annual wages in 2018. The median was $101,960.

Overall meaning biomedical engineers, in general the top 10% earned $144,350 annually, BLS data showed. In short, a six-figure salary is more than possible its probable. The more years of experience you have, the greater the likelihood of a high-paying job.

Other highly respected organizations and publications corroborate BLS facts and figures. The American Institute for Medical and Biomedical Engineering says bioengineers in research and development currently make the most on average at nearly $102,600. The typical bioengineering salary in pharmaceuticals is roughly $98,610 and $95,000 in medical equipment manufacturing.

As previously referenced, where a job may open in biomedical engineering in the U.S. can also influence actual earnings. According to the Economic Research Institute, in Pittsburgh, Pennsylvania, the average is $124,000, and nearby Columbus, the typical bioengineering salary is $146,000.

Meanwhile, in Massachusetts capital city of Boston, bioengineers earn $146,000 annually. Bioengineering salary levels are influenced by demand, the nature of the job and cost of living, among other factors.

The same goes for countries. While U.S.-based bioengineering salary levels are generally the most lucrative, others include Japan ($92,956 per year), Switzerland ($93,575) and Australia ($87,650), based on figures compiled by ERI.

These figures are all related to what the bioengineer salary is today. But what about tomorrow, meaning several years from now? Earnings are expected to surge, potentially by as much as 16% over a five-year period. Specifically, by 2024, the estimated salary could top $146,800, according to ERI.

If you have a passion for medicine but also enjoy the tasks that electronics engineers engage in, biomedical engineering is the perfect combination. It is a multidisciplinary profession that allows you to work in many different capacities toward the common goal of helping people experience longer more fulfilling lives. Whether it is the electrical circuitry that runs medical equipment or designing prosthetics that replace limbs, a biomedical engineering career is richly rewarding in more ways than one.

All this and much more is possible with an online Masters in Engineering degree from UC Riverside. Enjoy the flexibility of making your own schedule by completing the program entirely online; you dont need to live in California to do so. Better yet, the curriculum is custom designed with your busy schedule in mind, enabling you to complete and receive your diploma in 13 months time.

Apply now to learn and potentially earn more.

What You Need to Know about The Environmental Engineering Field

Bioengineering vs Environmental Engineering: How They Differ

University of California, Riverside Bioengineering Program

BLS Measuring the value of education

Economic Research Institute Bioengineer

BLS Biomedical Engineers

American Institute for Medical and Biological Engineering

View original post here:
Bioengineering: Career Path & Salary Averages | UC Riverside

Biomedical engineering, or bioengineering, is the application of engineering principles to the fields of biology and health care. Bioengineers work with doctors, therapists and researchers to develop systems, equipment and devices in order to solve clinical problems.

Biomedical engineers have developed a number of life-enhancing and life-saving technologies. These include:

The practice of biomedical engineering has a long history. One of the earliest examples is a wood and leatherprosthetic toefound on a 3,000-year-old Egyptian mummy. Before that, even simple crutches and walking sticks were a form of engineered assistive devices, and the first person to fashion a splint for a broken bone could be considered to have been an early biomedical engineer.

Biomedical engineering has evolved over the years in response to advancements in science and technology. Throughout history, humans have made increasingly more effective devices to diagnose and treat diseases and to alleviate, rehabilitate or compensate for disabilities or injuries. One example is the evolution of hearing aids to mitigate hearing loss through sound amplification. Theear trumpet, a large horn-shaped device that was held up to the ear, was the only "viable form" of hearing assistance until the mid-20th century, according to the Hearing Aid Museum. Electrical devices had been developed before then, but were slow to catch on, the museum said on its website.

The works ofAlexander Graham BellandThomas Edisonon sound transmission and amplification in the late 19th and early 20th centuries were applied to make the first tabletop hearing aids. These were followed by the first portable (or "luggable") devices using vacuum-tube amplifiers powered by large batteries. However, the first wearable hearing aids had to await the development of the transistor byWilliam Shockleyand his team at Bell Laboratories. Subsequent development of micro-integrated circuits and advance battery technology has led to miniature hearing aids that fit entirely within the ear canal.

Some notable figures in the history of biomedical engineering and their contributions include:

Biomedical engineers design and develop medical systems, equipment and devices. According to theU.S. Bureau of Labor Statistics(BLS), this requires in-depth knowledge of the operational principles of the equipment (electronic, mechanical, biological, etc.) as well as knowledge about the application for which it is to be used. For instance, in order to design an artificial heart, an engineer must have extensive knowledge ofelectrical engineering,mechanical engineeringandfluid dynamicsas well as an in-depth understanding of cardiology and physiology. Designing a lab-on-a-chip requires knowledge of electronics, nanotechnology, materials science and biochemistry. In order to design prosthetic replacement limbs, expertise in mechanical engineering and material properties as well as biomechanics and physiology is essential.

The critical skills needed by a biomedical engineer include a well-rounded understanding of several areas of engineering as well as the specific area of application. This could include studying physiology, organic chemistry, biomechanics or computer science. Continuing education and training are also necessary to keep up with technological advances and potential new applications.

Most biomedical engineering jobs require at least a bachelor's degree in biomedical engineering, according to the BLS. Many employers also require state certification as a professional engineer. A master's degree is often required for promotion to management, and ongoing education and training are needed to keep up with advances in technology, testing and monitoring equipment, computer hardware and software, and government regulations.

According toSalary.com, as of July 2014 the salary range for a newly graduated biomedical engineer with a bachelor's degree is $35,213 to $64,371. The range for a mid-level engineer with a master's degree and five to 10 years of experience is $51,404 to $84,098; and the range for a senior engineer with a master's degree or doctorate and more than 15 years of experience is $82,490 to $112,063. Many experienced engineers with advanced degrees are promoted to management positions where they can earn even more.

TheBLSprojects that employment of biomedical engineers will grow 27 percent from 2012 to 2022, much faster than the average for all occupations. Demand will be strong because an aging population is likely to need more medical care and because of increased public awareness of biomedical engineering advances and their benefits, according to the BLS.

Jim Lucas is a freelance writer and editor specializing in physics, astronomy and engineering. He is general manager ofLucas Technologies.

Read the original:
What Is Biomedical Engineering? | Live Science

Jurassic World Evolution launched in the same year as the second film in the rebooted blockbuster series and gave fans the opportunity to live out their own dreams of opening a theme park full of dinosaurs. Three years later, the games sequel looks to double down on that promise, putting even more tools and options in the hands of players. Jurassic World Evolution 2 cleverly expands upon what was built in the first game, delivering the definitive Jurassic experience.

In Jurassic World 2, players can build their own dinosaur theme park using enclosures, facilities, and scientists. Theres a lot of systems at play, and the core game is a balancing act of making sure your dinosaurs are taken care of and happy, guests are happy, and that your park is turning a profit.

Players are introduced to the games mechanics in Campaign mode. Set after the events of Jurassic World: Fallen Kingdom, players will work with the DFW (Department of Fish and Wildlife) to control, conserve, and contain the wild dinosaurs that now roam the planet. Each chapter of the Campaign has players in different locations looking to build a functioning park or conservation area. From Arizona, to Washington, California and more, it was neat to have a diverse offering of environments, rather than the jungle settings that we always see in Jurassic Park adaptations.

The Campaign is brief, easily beatable in a couple of sittings. That said, its a satisfying experience that eases players into the different systems that they will have to juggle. As someone who can sometimes feel overwhelmed in management sims, I felt equipped to deal with just about everything Jurassic World Evolution 2 threw at me. It was also cool having Jeff Goldblum and Bryce Dallas Howard reprise their roles from the films and serve as mentors throughout the story.

When building a successful park, theres a lot that players will need to take into account. Enclosures need to be built for every dinosaur, as to keep both the guests and creatures safe. Each species of dinosaur has its own unique needs that inform the player how to design their enclosure. For example, Velociraptors desire a lot of open space, as well as live prey to hunt down. The Carnotaurus wanted to be in a sandy environment, so I had to whip out the brush tool and make their enclosure look like a desert.

Theres over 75 species of dinosaurs featured in Jurassic World Evolution 2, and each one feels distinct from the next. This game also adds flying and marine creatures, adding more variety to what players can do with their parks.

Players can get a full read of everything they need to know about a dinosaur by pulling up its information page. This tells the player a dinosaurs comfort level, health status, genetic makeup, and even a stats page that will show you everything from a dinos age and dollar value, to how many creatures its killed and how many times it broke out of its enclosure. The amount of information the game gives makes each creature feel unique. I found myself growing attachments to some of the dinosaurs I had long term and I was genuinely saddened when they died or became unwell.

One of my favorite things to do in Jurassic World Evolution 2 was to hop into a ranger truck, and then drive around an enclosure in first-person. Seeing dinosaurs like the T-Rex and Brontosaurus up close, scaled to actual size, was incredible.

In addition to having cool dinosaurs and making sure theyre taken care of, players still need to manage a theme park. Buildings like viewing centers, restaurants, gift shops, and hotels make the guests happy, increasing profits. On the business side of things, operation facilities like the Control Center, Medical Facility, and Response Facility are integral to maintaining your park. Scientists can be hired to carry out tasks such as healing dinosaurs, going on expeditions to acquire new creatures, and conducting research in order to unlock new structures and perks. Each scientist has their own advantages and disadvantages, as well as a salary to match.

Theres a deep level of strategy and management just on the business side of things. Having to properly budget my income so that I could afford scientists, managing their time so that they didnt become fatigued or disgruntled. Fostering an environment that made my guests feel safe and excited to spend money was a good deal of fun on its own.

My only frustration with Jurassic World 2 comes in the repetitiveness of its gameplay loop, particularly early on in a playthrough. From random weather conditions, to illnesses and dinosaurs deciding to break fences and escape their enclosure, it can feel like youre in a constant state of panic, frequently pausing time to play an endless game of whack-a-mole. As more perks are unlocked, this becomes a bit less stressful.

One of the most fascinating mechanics in Jurassic World Evolution 2 is its bioengineering system, which lets players create their own dinosaurs just as Dr. Henry Wu and his team of scientists did in the films. Using a Hatchery, players can combine genomes from different species of reptiles in order to create a dinosaur thats wholly unique. These dinosaurs can have special behavioral traits, colors, and patterns. I spent a considerable amount of time just screwing around in Sandbox mode seeing what wild abominations I could come up with.

Chaos Theory is a new mode in Jurassic World Evolution 2 and puts players in scenarios from the Jurassic Park/World series, giving them a chance to rewrite history. These what if scenarios include realizing John Hammonds dream of building a Jurassic Park in San Diego, or maintaining Jurassic World on Isla Nublar without the incident in 2015. These missions offered a fresh challenge and are an excellent way to revisit major turning points in the franchise.

Jurassic World Evolution 2 is endless fun for a fan of the blockbuster franchise. A large library of species to unlock and study, bioengineering, and the ability to revisit iconic moments from the movies makes it an easy recommendation for anyone looking for their fix of Jurassic content. Even as a park manager, the game is quite satisfying, aside from some light frustrations here or there.

This review is based on a digital download code provided by the publisher. Jurassic World Evolution 2 is available now for $59.99 USD on PC, Xbox One, Xbox Series X, PS4, PS5, and PC.

Donovan is a young journalist from Maryland, who likes to game. His oldest gaming memory is playing Pajama Sam on his mom's desktop during weekends. Pokmon Emerald, Halo 2, and the original Star Wars Battlefront 2 were some of the most influential titles in awakening his love for video games. After interning for Shacknews throughout college, Donovan graduated from Bowie State University in 2020 with a major in broadcast journalism and joined the team full-time. He is a huge Star Wars nerd and film fanatic that will talk with you about movies and games all day. You can follow him on twitter @Donimals_

Read this article:
Jurassic World Evolution 2 review: When dinosaurs ruled the Earth - Shacknews

All News

November 18, 2020

Harvard University's Wyss Institute for Biologically Inspired Engineering has established its first research and innovation alliance by joining forces with Northpond Labs, the research and development-focused affiliate of a leading science and technology-driven venture capital firm, Northpond Ventures. Through the alliance, Northpond Labs will provide $12 million to create a Laboratory for Bioengineering Research and Innovation at the Wyss Institute and to support impactful research with strong translation potential.

The vision for the five-year strategic alliance was developed by senior leadership at Northpond Labs and the Wyss Institute, including Wyss Founding Director Donald Ingber and Northpond's Founder and CEO Michael Rubin. In close partnership with Harvard's Office of Technology Development (OTD), both groups have finalized the collaboration agreement and the agreement for the first funded research project.

As a first translation focus of the alliance, Northpond Labs through the Laboratory for Bioengineering Research and Innovation will sponsor research on the Wyss Institute's Controlled Enzymatic RNA Synthesis technology to accelerate its development toward commercialization. The novel synthesis approach was created in the Institutes Synthetic Biology platform and has been funded internally as a translationally focused Wyss Validation Project. The technology leverages a new enzyme-based method of generating synthetic RNA oligonucleotides, which have potential as RNA therapeutics, drug delivery vehicles, and genome engineering tools for a variety of disease applications. By using an engineered enzyme without the need for resource-intensive chemistry, it may provide a more effective and environmentally conscious way to synthesize RNA oligonucleotides than conventional chemical approaches used in industry.

The Wyss Institute has developed a new model for innovation, collaboration, and technology translation within academia, breaking historical silos to enable collaborations that cross institutional and disciplinary barriers. The unique translation model spans the full trajectory, from identifying high-value, real-world problems and developing disruptive technology solutions, to refining, optimizing, and validating these technologies so that they are well-positioned for impactful new licensing and start-up opportunities. This novel approach for technology translation within academia, working in collaboration with Harvard OTD, has so far yielded 3,291 patent filings and 75 licensing deals, including 39 new startups.

Through a separate arrangement with Harvard and the Wyss Institute, Northpond is providing an additional $3 million in funding to the Institute to support discovery efforts and to create and fund the Northpond Directors Innovation Fund. This fund will bolster the pursuit and growth of Wyss projects that have the potential to solve important unmet problems in the world, even when the path to commercialization remains unclear. In particular, the fund will be used to support early projects in areas including synthetic biology, biomanufacturing, synthesis of DNA and proteins, and clean water.

"This alliance represents an exciting new mechanism for supporting innovation and providing opportunities for translating discoveries that we at the Wyss Institute have made and are advancing inside academia. Given the Northpond team's deep experience in life sciences and technology, we are excited about the potential this collaboration offers for growth with their support and invaluable perspectives. We see this as the first of many such partnerships that the Wyss Institute will establish in the future," said Wyss Founding Director Donald Ingber, M.D., Ph.D., who is also theJudah Folkman Professor of Vascular Biologyat Harvard Medical School and the Vascular Biology Program at Boston Children's Hospital, and Professor of Bioengineering at Harvard John A. Paulson School of Engineering and Applied Sciences.

"We have been impressed by the collaborative and solutions-oriented approach to research at the Wyss Institute, and by the depth and breadth of innovations that it has generated," said Michael Rubin, M.D., Ph.D., Founder and CEO of Northpond Ventures and Labs. Rubin will collaborate with the Institute's Technology Translation Director, Angelika Fretzen, Ph.D., to help oversee the Laboratory for Bioengineering Research and Innovation and advance the shared vision. In addition to helping to oversee the Laboratorys program, Rubin will hold an appointment as a Visiting Scholar at the Wyss Institute, to enhance technology translation through community engagement and education.

This strategic alliance represents the first of what the Institute hopes will be multiple collaborations with the investment, corporate, and philanthropic communities that combine targeted investments in basic and applied research with flexible financial contributions; the goal of these collaborations is to sustain the remarkable level of innovation and intellectual property creation that the Institute has demonstrated since its founding almost 12 years ago.

All News

More:
Harvard's Wyss Institute creates research and innovation alliance with Northpond Labs - Harvard Office of Technology Development